Impact of the coronavirus disease 2019 pandemic on aortic valve replacement and outcomes in France
Graeme Prosperi‐Porta(University of Ottawa), David Messika–Zeitoun(University of Ottawa), Bernard Iung(Assistance Publique – Hôpitaux de Paris), Martine Gilard(Hôpital Maison Blanche), Nadav Willner(University of Ottawa), Alec Vahanian(Université Paris Cité), Ian G. Burwash(University of Ottawa), Christel Dindorf(Université Paris Cité), Alain Cribier(Hôpital Charles-Nicolle), Morgane Michel(Institut de Radioprotection et de Sûreté Nucléaire), Éric Durand(Centre Hospitalier Universitaire de Rouen), Virginia Nguyen(Centre Cardiologique du Nord), Karine Chevreul(Centre Hospitalier Universitaire Henri-Mondor), Hélène Eltchaninoff(Inserm), Julien Dreyfus(Centre Cardiologique du Nord)
Cited by 1
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k